Inhibition of FGD4 also resulted in reduced cell migration and CDC42 activities. »
12/17/18

Metabolic and mTOR activity alterations not related to recent glioma classification. »
12/19/18

OS benefit for axitinib versus everolimus in base-case analyses. »
12/19/18

Transmigration of MES stimulated by LPA. »
12/19/18

Each metric carries some independent risk-related information. »
12/19/18

Increased immune checkpoint receptor expression by circulating T regulatory cells associated with poor clinical outcomes. »
12/19/18

BMP5 expression positively correlated with E-cadherin in CRC patients. »
12/20/18

Negative function of microRNA-133a-3p on autophagy-mediated glutaminolysis. »
12/20/18

Model’s overall discrimination was modest area under the curve 0.59. »
12/20/18

High CCL22 expression generally seen in lower grade tumors. »
12/20/18